The US FDA has approved GSK’s Hibsago for chronic hepatitis B, with 19% of trial participants achieving a functional cure.

Shanghai, China - October 16, 2026 - MicroPort Scientific Corporation announced that it and its associated companies have reached a cumulative total of 50 products accepted into China's National ...

The Republican party’s confusing messaging on vaccines is going to hurt candidates in the midterms, two former GOP congressmen argue.

New MD Anderson studies report a Phase 3 immunotherapy advance in EGFR-mutant lung cancer, a dual role for B7-H3 in prostate ...

Ascentage Pharma Group International announced that lisaftoclax (APG-2575), the Company's novel Bcl-2 inhibitor, has been granted a Breakthrough Therapy Designation (BTD) by the Center for Drug ...

Anavex Life Sciences Corp. (“Anavex” or the “Company”), a clinical-stage biopharmaceutical company developing innovative treatments for central nervous system diseases with significant unmet medical ...

Presentation highlights new translational data evaluating plasma NfL and GFAP as biomarkers of neuroaxonal injury and neuroinflammationZUG, ...

Approval based on AZUR-1 data showing clinically significant proportion of participants with no detectable signs of cancer one year or more after treatment No disease recurrences reported ...

The 13-point charter also called for the restoration of GSCASH, the return of JNUEE and action on wider concerns over campus ...

$2,220,000 of JOHNSON & JOHNSON SERVICES INC lobbying was just disclosed, from Q3 of 2026, in a new Lobbying Disclosure Act ...

Texas hospital uses Skincubator technology to help parents hold premature babies safely. Learn more about this innovation.

Spread the love“`html Google’s recent strides in artificial intelligence, particularly in the medical field, have been nothing short of breathtaking. We’re talking about AI systems that can achieve ...